Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-07-06
1983-09-13
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31155
Patent
active
044042264
ABSTRACT:
This invention provides a new neuroleptic use of a guanidine derivative and novel pharmaceutical compositions for such use.
REFERENCES:
J. Clin. Pharmac. 7, pp. 221-225 (1967).
Biological Psychiatry 15, pp. 45-57, (1980).
Communications in Psychopharmacology 4, pp. 507-517 (1980).
Chem. Abst. vol. 93, (1980), 125813U.
Kleinlogel Horst
Matejcek Milan
Theohar Carl
Borovian Joseph J.
Friedman Stanley J.
Honor Robert S.
Sandoz Ltd.
Sharkin Gerald D.
LandOfFree
Use of guanfacine in treating schizophrenia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of guanfacine in treating schizophrenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of guanfacine in treating schizophrenia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1729870